These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 204545)

  • 1. Established cell lines as tools in the study of human lymphoma and myeloma cell characteristics.
    Nilsson K
    Haematol Blood Transfus; 1977; 20():253-64. PubMed ID: 204545
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of a human Hodgkin cell line and a lymphoblastic EBNA-negative cell line derived from a non-Hodgkin lymphoma patient.
    Gallmeier WM; Boecker WR; Bruntsch U; Hossfeld DK; Schmidt CG
    Haematol Blood Transfus; 1977; 20():277-81. PubMed ID: 204548
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of "T" and "non-T" cell lines established from children with acute lymphoblastic leukemia and non-Hodgkin lymphoma after leukemic transformation.
    Schneider U; Schwenk HU
    Haematol Blood Transfus; 1977; 20():265-9. PubMed ID: 204546
    [No Abstract]   [Full Text] [Related]  

  • 4. Membrane receptor stripping confirms the association between EBV receptors and complement receptors on the surface of human B lymphoma lines.
    Yefenof E; Klein G
    Int J Cancer; 1977 Sep; 20(3):347-52. PubMed ID: 198382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment in continuous culture of a T-lymphoid cell line (HD-Mar) from a patient with Hodgkin's lymphoma.
    Ben-Bassat H; Mitrani-Rosenbaum S; Gamliel H; Naparstek E; Leizerowitz R; Korkesh A; Sagi M; Voss R; Kohn G; Polliack A
    Int J Cancer; 1980 May; 25(5):583-90. PubMed ID: 6154663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and characterization of a truly leukaemic cell line.
    Rosenfeld C; Goutner A; Kayibanda B; Venuat AM; Choquet C; Pico J; Petitou M; Lorans G; Tuy F; Desgrange C; Bornkamm G; Dore JF; de The G
    Haematol Blood Transfus; 1977; 20():271-6. PubMed ID: 204547
    [No Abstract]   [Full Text] [Related]  

  • 7. Human B cell, T cell and null cell leukaemic cell lines derived from acute lymphoblastic leukaemias.
    Miyoshi I; Hiraki S; Tsubota T; Kubonishi I; Matsuda Y; Nakayama T; Kishimoto H; Kimura I; Masuji H
    Nature; 1977 Jun; 267(5614):843-4. PubMed ID: 197412
    [No Abstract]   [Full Text] [Related]  

  • 8. Critical evaluation of B and T cell markers in man.
    Preud'Homme JL; Seligmann M
    Rheumatology; 1975; 6():178-89. PubMed ID: 53874
    [No Abstract]   [Full Text] [Related]  

  • 9. Surface receptors on human haematopoietic cell lines.
    Huber C; Sundström C; Nilsson K; Wigzell H
    Clin Exp Immunol; 1976 Sep; 25(3):367-76. PubMed ID: 963908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological properties of lymphoblastoid cell lines (UHKT) - 1, 2, 3, 4, 5, 6) established from cases of human leukemias.
    Koubek K; Stockbauer P; Herzog P; Roubal J; Praehová K; Cinátl J; Korínková P; Michalová K
    Czech Med; 1983; 6(3):159-68. PubMed ID: 6315324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation between benign and malignant human lymph nodes by means of immunologic markers.
    Brubaker DB; Whiteside TL
    Cancer; 1979 Apr; 43(4):1165-76. PubMed ID: 376086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and characterization of a human null-cell lymphoblastic lymphoma cell line (K-LL-3).
    Smith SD; Rosen D
    Int J Cancer; 1979 Apr; 23(4):494-503. PubMed ID: 220200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nodular lymphocyte predominance type of Hodgkin's disease is a B cell lymphoma.
    Poppema S; Timens W; Visser L
    Adv Exp Med Biol; 1985; 186():963-9. PubMed ID: 2931963
    [No Abstract]   [Full Text] [Related]  

  • 14. Lymphoid cell line identification and the detection of cross contamination.
    Conner BR; Ferrone S; Pellegrino MA; Glaser R
    In Vitro; 1980 May; 16(5):446-52. PubMed ID: 6248453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inducibility of the Epstein-Barr virus (EBV) cycle and surface marker properties of EBV-negative lymphoma lines and their in vitro EBV-converted sublines.
    Klein G; Zeuthen J; Terasaki P; Billing R; Honig R; Jondal M; Westman A; Clements G
    Int J Cancer; 1976 Nov; 18(5):639-52. PubMed ID: 62724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalogue of Epstein-Barr virus (EBV) receptors on human malignant and non-malignant hematopoietic cell lines.
    Tatsumi E; Harada S; Kuszynski C; Volsky D; Minowada J; Purtilo DT
    Leuk Res; 1985; 9(2):231-8. PubMed ID: 2985880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface markers on human B and T-lymphocytes. IX. Two-color immunofluorescence studies on the association between ebv receptors and complement receptors on the surface of lymphoid cell lines.
    Yefenof E; Klein G; Jondal M; Oldstone MB
    Int J Cancer; 1976 Jun; 17(6):693-700. PubMed ID: 181330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification and biological nature of established human hematopoietic cell lines.
    Nilsson K; Pontén J
    Int J Cancer; 1975 Feb; 15(2):321-41. PubMed ID: 165156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human lymph node lymphocytes fail to effect lysis of antibody-coated target cells.
    O'Toole C; Saxon A; Bohrer R
    Clin Exp Immunol; 1977 Jan; 27(1):165-71. PubMed ID: 300304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus (EBV) receptors, complement receptors, and EBV infectibility of different lymphocyte fractions of human peripheral blood. I. Complement receptor distribution and complement binding by separated lymphocyte subpopulations.
    Yefenof E; Bakacs T; Einhorn L; Ernberg I; Klein G
    Cell Immunol; 1978 Jan; 35(1):34-42. PubMed ID: 340053
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.